US HB4626 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Republican 11-0)
Status: Introduced on July 13 2023 - 25% progression, died in committee
Action: 2023-07-14 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 13 2023 - 25% progression, died in committee
Action: 2023-07-14 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To encourage sponsors of oral contraceptive drugs to submit applications for the approval of such drugs as over-the-counter, and for other purposes.
Title
OTC Act of 2023 Orally Taken Contraception Act of 2023
Sponsors
Rep. Mariannette Miller-Meeks [R-IA] | Rep. Jennifer Kiggans [R-VA] | Rep. Marjorie Greene [R-GA] | Rep. Stephanie Bice [R-OK] |
Rep. Maria Salazar [R-FL] | Rep. Lori Chavez-DeRemer [R-OR] | Rep. Nicole Malliotakis [R-NY] | Rep. Young Kim [R-CA] |
Rep. Diana Harshbarger [R-TN] | Rep. Nancy Mace [R-SC] | Rep. Ashley Hinson [R-IA] |
History
Date | Chamber | Action |
---|---|---|
2023-07-14 | House | Referred to the Subcommittee on Health. |
2023-07-13 | House | Referred to the House Committee on Energy and Commerce. |
2023-07-13 | House | Introduced in House |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/4626/all-info |
Text | https://www.congress.gov/118/bills/hr4626/BILLS-118hr4626ih.pdf |